Approvals Granted to Begin LYS-GM101 Clinical Trial for GM1 Gangliosidosis
source: pixabay.com

Approvals Granted to Begin LYS-GM101 Clinical Trial for GM1 Gangliosidosis

In an exciting press release, gene therapy platform company Lysogene announced that it had received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) and Research Ethics Committee. As…

Continue Reading Approvals Granted to Begin LYS-GM101 Clinical Trial for GM1 Gangliosidosis
First Patient Dosed in Phase I/II Study of Experimental Gene Therapy for Cystinosis
source: pixabay.com

First Patient Dosed in Phase I/II Study of Experimental Gene Therapy for Cystinosis

According to a recent press release from the Massachusetts-based biotechnology company Avrobio, Inc., the first patient has been dosed in the Company's phase I/II clinical study of their investigational cystinosis…

Continue Reading First Patient Dosed in Phase I/II Study of Experimental Gene Therapy for Cystinosis
Patient Advocacy Groups Call for Indian Health Ministry to Implement Interim Care Policy for Rare Disease Patients
Pexels / Pixabay

Patient Advocacy Groups Call for Indian Health Ministry to Implement Interim Care Policy for Rare Disease Patients

According to a recent publication from Moneycontrol, patient advocacy groups in India are calling for the country's Minister of Health and Family Welfare, Harsh Vardhan, to establish a provisional system…

Continue Reading Patient Advocacy Groups Call for Indian Health Ministry to Implement Interim Care Policy for Rare Disease Patients
Neurogene Sponsors Invitae’s No-Charge Genetic Testing Program for Suspected Lysosomal Disease Patients
qimono / Pixabay

Neurogene Sponsors Invitae’s No-Charge Genetic Testing Program for Suspected Lysosomal Disease Patients

According to a press release from American biotechnology company Neurogene, the Company has kicked off a sponsorship of Invitae Corporation's "Detect Lysosomal Storage Diseases" program, which will offer genetic testing…

Continue Reading Neurogene Sponsors Invitae’s No-Charge Genetic Testing Program for Suspected Lysosomal Disease Patients
How Planning a Wedding Solved the Riddle of a Sister’s Mysterious Illness
Source: Pixabay.com

How Planning a Wedding Solved the Riddle of a Sister’s Mysterious Illness

The Heritage Florida Jewish News reported a story about one sister's journey to her Gaucher Disease diagnosis, thanks to her older sister's wedding prep. What is Gaucher Disease? Gaucher disease…

Continue Reading How Planning a Wedding Solved the Riddle of a Sister’s Mysterious Illness
Patients Are Being Asked for Their Opinions on Treatments For Lysosomal Storage Diseases
Source: Pixabay

Patients Are Being Asked for Their Opinions on Treatments For Lysosomal Storage Diseases

In an effort to better understand patient experiences, researchers at the Massachusetts General Hospital are surveying people with lysosomal storage diseases about how they view their treatments, reports CheckOrphan. The…

Continue Reading Patients Are Being Asked for Their Opinions on Treatments For Lysosomal Storage Diseases